in this issue
People & Business :: Companies
Metabolix Enacts Shareholder Rights Plan
3:11 PM MDT | July 7, 2009 | Vincent Valk
Metabolix (Cambridge, MA) has enacted a shareholder rights plan, the company announced today. The plan "ensures that shareholders receive fair treatment in the event of any coercive takeover attempt," says Metabolix CEO Richard Eno. However, it " was not adopted in response to any current effort to acquire control of the company," he adds. The plan includes a poison pill provision that takes effect in the event of an attempt to buy 15% or more of the company. The provision allows holders of common stock to exercise a right to purchase...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee